Investors

Abalos Therapeutics is supported by a syndicate of prestigious life science investors including Boehringer Ingelheim Venture Funds, High-Tech Gründerfonds, NRW.Bank and Gründerfonds Ruhr.

Partners

We have established successful relationships with renowned academic and service partners and are always looking out for new collaborations to further advance our innovative immuno-virotherapy approach.